{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:39:31Z","timestamp":1794627571435,"version":"4.9.1"},"reference-count":204,"publisher":"Oxford University Press (OUP)","issue":"26","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019719","name":"Chiesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021515","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021515","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013220","name":"Ultragenyx","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013220","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Familial hypercholesterolaemia (FH) is a common genetic disorder characterized by lifelong elevated LDL cholesterol (LDL-C) concentrations. FH exists in two forms: heterozygous FH (HeFH), which affects around 1 in 300 people worldwide, and homozygous FH (HoFH), which affects around 1 in 300 000. Individuals with FH are at increased risk of premature atherosclerotic cardiovascular disease (ASCVD) and death, and those with HoFH are, if untreated, at extreme risk of ASCVD manifestations even before adulthood. Early diagnosis and treatment in childhood can extend or normalize life expectancy, but limited awareness, underdiagnosis, and undertreatment remain major challenges. This consensus statement aims to address these challenges, supported by increased knowledge of the pathogenesis of FH and the availability of an increasing range of lipid-lowering therapies (LLTs) that can be used from early ages. To increase the detection rate of FH, all countries are encouraged to establish a paediatric screening programme and, given that current diagnostic criteria often fail to identify children with an FH-causing genetic variant, revised diagnostic criteria are presented. Updated LDL-C treatment goals are proposed, and the importance of starting LLTs before puberty in children with HeFH, and, if needed, from 6 years, is highlighted. Guidance on how to manage FH is provided, including treatment algorithms for use in children with either HeFH or HoFH and a discussion on how to promote a smooth transition to adult care. Early detection and optimal treatment as advocated in this consensus statement are crucial to improving life expectancy for children and adolescents with FH.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehag382","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:20:56Z","timestamp":1777893656000},"page":"3324-3346","source":"Crossref","is-referenced-by-count":29,"title":["Familial hypercholesterolaemia in children and adolescents: a European Atherosclerosis Society consensus statement"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6223-5671","authenticated-orcid":false,"given":"Albert","family":"Wiegman","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Amsterdam University Medical Center, Location AMC , Meibergdreef 9, Amsterdam 1105 AZ ,","place":["The Netherlands"]},{"name":"Amsterdam Cardiovascular Sciences Research Institute, Amsterdam UMC, University of Amsterdam , Meibergdreef 9, Amsterdam 1105 AZ ,","place":["The Netherlands"]},{"name":"Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam UMC , Meibergdreef 9, Amsterdam 1105 AZ ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8843-3799","authenticated-orcid":false,"given":"Mafalda","family":"Bourbon","sequence":"additional","affiliation":[{"name":"Unidade de Investiga\u00e7\u00e3o e Desenvolvimento, Grupo de Investiga\u00e7\u00e3o Cardiovascular, Departamento de Promo\u00e7\u00e3o da Sa\u00fade e Preven\u00e7\u00e3o de Doen\u00e7as N\u00e3o Transmiss\u00edveis, Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge , Lisbon ,","place":["Portugal"]},{"name":"Centro Cardiovascular Universidade de Lisboa (CCUL@RISE), Faculdade de Medicina, Universidade de Lisboa , Lisbon ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6532-7053","authenticated-orcid":false,"given":"Tomas","family":"Freiberger","sequence":"additional","affiliation":[{"name":"Centre of Cardiovascular Surgery and Transplantation Brno, and Medical Faculty, Masaryk University , Brno ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8557-7225","authenticated-orcid":false,"given":"Samuel S","family":"Gidding","sequence":"additional","affiliation":[{"name":"Department of Genomic Health, Geisinger , Danville, PA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3706-8370","authenticated-orcid":false,"given":"Susanne","family":"Greber-Platzer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Division of Pediatric Pulmonology, Allergology and Endocrinology, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5246-9869","authenticated-orcid":false,"given":"Urh","family":"Groselj","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Ljubljana , Ljubljana ,","place":["Slovenia"]},{"name":"Department of Endocrinology, Diabetes, and Metabolic Diseases, University Children's Hospital, University Medical Centre Ljubljana , Ljubljana ,","place":["Slovenia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8674-9703","authenticated-orcid":false,"given":"Kirsten B","family":"Holven","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo , Oslo ,","place":["Norway"]},{"name":"Norwegian National Network on Familial Hypercholesterolemia, Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8560-9477","authenticated-orcid":false,"given":"Lisa C","family":"Hudgins","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology, Weill Cornell Medical College , NewYork, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve E","family":"Humphries","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, Faculty of Population Health, University College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9243-0037","authenticated-orcid":false,"given":"Barbara A","family":"Hutten","sequence":"additional","affiliation":[{"name":"Amsterdam Cardiovascular Sciences Research Institute, Amsterdam UMC, University of Amsterdam , Meibergdreef 9, Amsterdam 1105 AZ ,","place":["The Netherlands"]},{"name":"Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam UMC , Meibergdreef 9, Amsterdam 1105 AZ ,","place":["The Netherlands"]},{"name":"Department of Epidemiology and Data Science, Amsterdam University Medical Center, University of Amsterdam , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5442-1930","authenticated-orcid":false,"given":"Daiana","family":"Ibarretxe","sequence":"additional","affiliation":[{"name":"Unitat de Medicina Vascular i Metabolisme, Hospital Universitari Sant Joan, IISPV, CIBERDEM, Universitat Rovira i Virgili , Reus ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2213-9383","authenticated-orcid":false,"given":"Cristina","family":"Pederiva","sequence":"additional","affiliation":[{"name":"Paediatrics Unit, Clinical Service for Dyslipidaemias, Study and Prevention of Atherosclerosis in Childhood, ASST-Santi Paolo e Carlo , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8359-5163","authenticated-orcid":false,"given":"Noel","family":"Peretti","sequence":"additional","affiliation":[{"name":"CarMeN Laboratory, INSERM U1060, INRAE U1397, Universit\u00e9 Claude Bernard Lyon , Lyon ,","place":["France"]},{"name":"Department of Pediatric Gastroenterology-Hepatology and Nutrition, H\u00f4pital Femme Mere Enfant HFME, Hospices Civils de Lyon HCL , Bron ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9170-7938","authenticated-orcid":false,"given":"Frederick J","family":"Raal","sequence":"additional","affiliation":[{"name":"Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Ramaswami","sequence":"additional","affiliation":[{"name":"Royal Free London NHS Foundation Trust, University College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5371-7230","authenticated-orcid":false,"given":"Veronika","family":"Sanin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Deutsches Herzzentrum M\u00fcnchen, Klinikum der Technischen, Universit\u00e4t M\u00fcnchen , Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul D","family":"Santos","sequence":"additional","affiliation":[{"name":"Academic Research Organization, Hospital Israelita Albert Einstein and Lipid Clinic Heart Institute (InCor), University of S\u00e3o Paulo , S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Steinhagen-Thiessen","sequence":"additional","affiliation":[{"name":"Lipid Clinic at the Interdisciplinary Metabolism Center, Charit\u00e9-University Medicine Berlin , Berlin ,","place":["Germany"]},{"name":"Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Rostock , Rostock ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2276-1524","authenticated-orcid":false,"given":"Gerald F","family":"Watts","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Western Australia , Perth ,","place":["Australia"]},{"name":"Department of Cardiology, Royal Perth Hospital , Western Australia ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2447-3286","authenticated-orcid":false,"given":"Rosie","family":"Perkins","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1701-595X","authenticated-orcid":false,"given":"Marianne","family":"Benn","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital-Rigshospitalet, Centre of Diagnostic Investigation , Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8313-7050","authenticated-orcid":false,"given":"Christoph J","family":"Binder","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9168-4898","authenticated-orcid":false,"given":"Stefano","family":"Romeo","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]},{"name":"Department of Medicine (H7), Karolinska Institute , Huddinge, Stockholm ,","place":["Sweden"]},{"name":"Department of Endocrinology, Karolinska University Hospital , Huddinge, Stockholm ,","place":["Sweden"]},{"name":"Department of Cardiology, Sahlgrenska University Hospital , Gothenburg ,","place":["Sweden"]},{"name":"Clinical Nutrition Unit, Department of Medical and Surgical Sciences, University Magna Graecia , Catanzaro ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6870-9962","authenticated-orcid":false,"given":"Jeanine E","family":"Roeters van Lennep","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardiovascular Institute, Erasmus Medical Center , Dr Molewaterplein 40, Rotterdam 3015 GD ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the European Atherosclerosis Society Consensus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutaz","family":"Al-Khnifsawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Daccord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat","family":"Ezhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tea","family":"Gamezardashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dov","family":"Gavish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Gerdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Gouni-Berthold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Guijarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baris","family":"Gungor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Kronenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirkka-Pekka","family":"Laurila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Menown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkin","family":"Mirrakhimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Mitchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demosthenes","family":"Panagiotakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christodoulos","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Parcero Vald\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeljko","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Scicali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander B","family":"Shek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sekib","family":"Sokolovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Storozhenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phivos","family":"Symeonides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlis","family":"Trusinskis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Vrablik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"2026092914373098500_ehag382-B1","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia","volume":"75","author":"Beheshti","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026092914373098500_ehag382-B2","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"key":"2026092914373098500_ehag382-B3","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society consensus panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"2026092914373098500_ehag382-B4","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur Heart J"},{"key":"2026092914373098500_ehag382-B5","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1093\/eurheartj\/ehad197","article-title":"2023 update on European Atherosclerosis Society consensus statement on homozygous familial hypercholesterolaemia: new treatments and clinical guidance","volume":"44","author":"Cuchel","year":"2023","journal-title":"Eur Heart J"},{"key":"2026092914373098500_ehag382-B6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(23)01842-1","article-title":"Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study","volume":"403","author":"Dharmayat","year":"2024","journal-title":"Lancet"},{"key":"2026092914373098500_ehag382-B7","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/S0140-6736(21)01122-3","article-title":"Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)","volume":"398","author":"Vallejo-Vaz","year":"2021","journal-title":"Lancet"},{"key":"2026092914373098500_ehag382-B8","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1093\/eurheartj\/ehac224","article-title":"Screening in children for familial hypercholesterolaemia: start now","volume":"43","author":"Groselj","year":"2022","journal-title":"Eur Heart J"},{"key":"2026092914373098500_ehag382-B9","doi-asserted-by":"publisher","first-page":"oeaf001","DOI":"10.1093\/ehjopen\/oeaf001","article-title":"Management of children with heterozygous familial hypercholesterolaemia worldwide: a meta-analysis","volume":"5","author":"Byty\u00e7i","year":"2025","journal-title":"Eur Heart J Open"},{"key":"2026092914373098500_ehag382-B10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jacl.2022.01.009","article-title":". Intima-media thickness in treated and untreated patients with and without familial hypercholesterolemia: a systematic review and meta-analysis","volume":"16","author":"Van Bergen En Henegouwen","year":"2022","journal-title":"J Clin Lipidol"},{"key":"2026092914373098500_ehag382-B11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0140-6736(04)15467-6","article-title":"Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia","volume":"363","author":"Wiegman","year":"2004","journal-title":"Lancet"},{"key":"2026092914373098500_ehag382-B12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1161\/CIRCRESAHA.114.301430","article-title":"Carotid intima-media thickness in children with familial hypercholesterolemia","volume":"114","author":"Kusters","year":"2014","journal-title":"Circ Res"},{"key":"2026092914373098500_ehag382-B13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0021-9150(02)00003-5","article-title":"Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia","volume":"163","author":"De Jongh","year":"2002","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/eurjpc\/zwaf301","article-title":"Clinical scores fail to sufficiently identify children with familial hypercholesterolemia","volume":"33","author":"Schmieder","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"2026092914373098500_ehag382-B15","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 focused update of the 2019 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"46","author":"Mach","year":"2025","journal-title":"Eur Heart J"},{"key":"2026092914373098500_ehag382-B16","doi-asserted-by":"publisher","first-page":"102542","DOI":"10.1016\/j.jacadv.2025.102542","article-title":"Lipoprotein(a) and the early diagnosis, complexity, and extent of coronary artery disease and myocardial infarction","volume":"5","author":"Coerkamp","year":"2026","journal-title":"JACC Adv"},{"key":"2026092914373098500_ehag382-B17","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1515\/CCLM.2008.135","article-title":"Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing","volume":"46","author":"Starr","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"2026092914373098500_ehag382-B18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1210\/clinem\/dgad625","article-title":"High lipoprotein(a) may explain one-quarter of clinical familial hypercholesterolemia diagnoses in Danish lipid clinics","volume":"109","author":"Hedegaard","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026092914373098500_ehag382-B19","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1093\/eurheartj\/ehac660","article-title":"Lipoprotein(a) levels in children with suspected familial hypercholesterolaemia: a cross-sectional study","volume":"44","author":"De Boer","year":"2023","journal-title":"Eur Heart J"},{"key":"2026092914373098500_ehag382-B20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2022.04.015","article-title":"Lipoprotein(a) and cardiovascular and valvular diseases: a genetic epidemiological perspective","volume":"349","author":"Arsenault","year":"2022","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B21","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Scientific Steering Committee on behalf of the Simon Broome Register Group","volume":"303","author":"Risk of fatal coronary heart disease in familial hypercholesterolaemia","year":"1991","journal-title":"BMJ"},{"key":"2026092914373098500_ehag382-B22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1055\/s-2004-822987","article-title":"Advanced method for the identification of patients with inherited hypercholesterolemia","volume":"4","author":"Defesche","year":"2004","journal-title":"Semin Vasc Med"},{"key":"2026092914373098500_ehag382-B23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics","volume":"72","author":"Williams","year":"1993","journal-title":"Am J Cardiol"},{"key":"2026092914373098500_ehag382-B24","doi-asserted-by":"publisher","first-page":"zwaf352","DOI":"10.1093\/eurjpc\/zwaf352","article-title":"Proposal of a familial hypercholesterolemia paediatric diagnostic score (FH-PeDS)","author":"Kafol","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"2026092914373098500_ehag382-B25","doi-asserted-by":"publisher","first-page":"zwaf565","DOI":"10.1093\/eurjpc\/zwaf565","article-title":"Screening for familial hypercholesterolaemia: children are not small adults","author":"Bittner","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"2026092914373098500_ehag382-B26","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jacl.2020.04.011","article-title":"Genetic testing in dyslipidemia: a scientific statement from the National Lipid Association","volume":"14","author":"Brown","year":"2020","journal-title":"J Clin Lipidol"},{"key":"2026092914373098500_ehag382-B27","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical genetic testing for familial hypercholesterolemia","volume":"72","author":"Sturm","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026092914373098500_ehag382-B28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.gim.2021.09.012","article-title":"The Clinical Genome Resource (ClinGen) familial hypercholesterolemia variant curation expert panel consensus guidelines for LDLR variant classification","volume":"24","author":"Chora","year":"2022","journal-title":"Genet Med"},{"key":"2026092914373098500_ehag382-B29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/MOL.0000000000000937","article-title":"APOE and familial hypercholesterolemia","volume":"35","author":"Civeira","year":"2024","journal-title":"Curr Opin Lipidol"},{"key":"2026092914373098500_ehag382-B30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.atherosclerosis.2013.09.038","article-title":"Non-cholesterol sterols and cholesterol metabolism in sitosterolemia","volume":"231","author":"Othman","year":"2013","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B31","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/978-3-662-63123-2_36","volume-title":"Inborn Metabolic Diseases: Diagnosis and Treatment","author":"Ramaswami","year":"2022"},{"key":"2026092914373098500_ehag382-B32","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.jacl.2022.08.009","article-title":"Guidance for the diagnosis and treatment of hypolipidemia disorders","volume":"16","author":"Bredefeld","year":"2022","journal-title":"J Clin Lipidol"},{"key":"2026092914373098500_ehag382-B33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.atherosclerosis.2019.01.036","article-title":"Molecular analysis of APOB, SAR1B, ANGPTL3, and MTTP in patients with primary hypocholesterolemia in a clinical laboratory setting: evidence supporting polygenicity in mutation-negative patients","volume":"283","author":"Blanco-Vaca","year":"2019","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B34","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/humu.21660","article-title":"Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl levels","volume":"33","author":"Huijgen","year":"2012","journal-title":"Hum Mutat"},{"key":"2026092914373098500_ehag382-B35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/MOL.0000000000000863","article-title":"Genotype\u2013phenotype correlation in a large cohort of pediatric patients with heterozygous and homozygous familial hypercholesterolemia","volume":"34","author":"Reijman","year":"2023","journal-title":"Curr Opin Lipidol"},{"key":"2026092914373098500_ehag382-B36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s12687-018-0373-5","article-title":"Parents\u2019 views of genetic testing and treatment of familial hypercholesterolemia in children: a qualitative study","volume":"10","author":"Keenan","year":"2019","journal-title":"J Community Genet"},{"key":"2026092914373098500_ehag382-B37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2020.11.027","article-title":"Genetic testing is essential for initiating statin therapy in children with familial hypercholesterolemia: examples from Scandinavia","volume":"316","author":"Svendsen","year":"2021","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B38","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.3390\/medicina60101602","article-title":"The importance of genetic testing for familial hypercholesterolemia: a Pediatric Pilot Study","volume":"60","author":"Constantin","year":"2024","journal-title":"Medicina"},{"key":"2026092914373098500_ehag382-B39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jpeds.2022.08.041","article-title":"Factors predicting statin initiation during childhood in familial hypercholesterolemia: importance of genetic diagnosis","volume":"253","author":"Peretti","year":"2023","journal-title":"J Pediatr"},{"key":"2026092914373098500_ehag382-B40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12529-025-10357-y","article-title":"Facilitators and barriers to uptake of genetic and cascade testing in familial hypercholesterolemia: a systematic review","volume":"33","author":"Lenin","year":"2026","journal-title":"Int J Behav Med"},{"key":"2026092914373098500_ehag382-B41","first-page":"215","volume-title":"Handbook of Children\u2019s Coping. Issues in Clinical Child Psychology","author":"Lutzke","year":"1997"},{"key":"2026092914373098500_ehag382-B42","doi-asserted-by":"publisher","first-page":"e1001679","DOI":"10.1371\/journal.pmed.1001679","article-title":"Mortality after parental death in childhood: a nationwide cohort study from three Nordic countries","volume":"11","author":"Li","year":"2014","journal-title":"PLoS Med"},{"key":"2026092914373098500_ehag382-B43","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1373\/clinchem.2014.231365","article-title":"Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries","volume":"61","author":"Futema","year":"2015","journal-title":"Clin Chem"},{"key":"2026092914373098500_ehag382-B44","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"key":"2026092914373098500_ehag382-B45","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.atherosclerosis.2018.06.006","article-title":"Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia","volume":"277","author":"Futema","year":"2018","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B46","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/tbm\/ibac018","article-title":"Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication","volume":"12","author":"Campbell-Salome","year":"2022","journal-title":"Transl Behav Med"},{"key":"2026092914373098500_ehag382-B47"},{"key":"2026092914373098500_ehag382-B48","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.2105\/AJPH.85.12.1673","article-title":"The tracking of nutrient intake in young children: the Framingham Children\u2019s Study","volume":"85","author":"Singer","year":"1995","journal-title":"Am J Public Health"},{"key":"2026092914373098500_ehag382-B49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/07315724.2005.10719448","article-title":"A review of family and social determinants of children\u2019s eating patterns and diet quality","volume":"24","author":"Patrick","year":"2005","journal-title":"J Am Coll Nutr"},{"key":"2026092914373098500_ehag382-B50","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S2352-4642(20)30059-6","article-title":"Effects of 20-year infancy-onset dietary counselling on cardiometabolic risk factors in the Special Turku Coronary Risk Factor Intervention Project (STRIP): 6-year post-intervention follow-up","volume":"4","author":"Pahkala","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"2026092914373098500_ehag382-B51","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1136\/bmj.39300.616076.55","article-title":"Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis","volume":"335","author":"Wald","year":"2007","journal-title":"BMJ"},{"key":"2026092914373098500_ehag382-B52","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3390\/genes12081168","article-title":"Successful genetic screening and creating awareness of familial hypercholesterolemia and other heritable dyslipidemias in The Netherlands","volume":"12","author":"Zuurbier","year":"2021","journal-title":"Genes (Basel)"},{"key":"2026092914373098500_ehag382-B53","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.33549\/physiolres.933600","article-title":"Familial hypercholesterolemia in the Czech republic: more than 17 years of systematic screening within the MedPed project","volume":"66","author":"Vrabl\u00edk","year":"2017","journal-title":"Physiol Res"},{"key":"2026092914373098500_ehag382-B54","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1016\/j.gim.2022.06.010","article-title":"Universal screening for familial hypercholesterolemia in 2 populations","volume":"24","author":"Sustar","year":"2022","journal-title":"Genet Med"},{"key":"2026092914373098500_ehag382-B55","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1093\/eurjpc\/zwac200","article-title":"Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations","volume":"29","author":"Gidding","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2026092914373098500_ehag382-B56","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1001\/jamapediatrics.2023.0763","article-title":"Cost-effectiveness and return on investment of a nationwide case-finding program for familial hypercholesterolemia in children in The Netherlands","volume":"177","author":"Ademi","year":"2023","journal-title":"JAMA Pediatr"},{"key":"2026092914373098500_ehag382-B57","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jacl.2021.08.007","article-title":"The importance of cascade genetic screening for diagnosing autosomal dominant hypercholesterolemia: results from twenty years of a national screening program in Norway","volume":"15","author":"Leren","year":"2021","journal-title":"J Clin Lipidol"},{"key":"2026092914373098500_ehag382-B58","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2018.06.858","article-title":"Universal screening for familial hypercholesterolemia in children: the Slovenian model and literature review","volume":"277","author":"Groselj","year":"2018","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B59","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jacc.2015.07.017","article-title":"Universal screening for Familial Hypercholesterolemia in Children","volume":"66","author":"Klan\u010dar","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026092914373098500_ehag382-B60","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/eurpub\/ckac007","article-title":"Population-based screening in children for early diagnosis and treatment of familial hypercholesterolemia: design of the VRONI study","volume":"32","author":"Sanin","year":"2022","journal-title":"Eur J Public Health"},{"key":"2026092914373098500_ehag382-B61","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.atherosclerosis.2018.05.047","article-title":"Universal screening at age 1\u20132 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: a cost-utility analysis","volume":"275","author":"McKay","year":"2018","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B62","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.vhri.2022.08.009","article-title":"Cost-effectiveness of pediatric universal screening for familial hypercholesterolemia in Argentina","volume":"33","author":"Araujo","year":"2023","journal-title":"Value Health Reg Issues"},{"key":"2026092914373098500_ehag382-B63","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1001\/jama.2025.20648","article-title":"Familial hypercholesterolemia screening in childhood and early adulthood: a cost-effectiveness study","volume":"335","author":"Bellows","year":"2026","journal-title":"JAMA"},{"key":"2026092914373098500_ehag382-B64","doi-asserted-by":"publisher","first-page":"117231","DOI":"10.1016\/j.atherosclerosis.2023.117231","article-title":"Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: evidence from the LIPIGEN study","volume":"385","author":"Casula","year":"2023","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B65","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/children12030288","article-title":"Diagnosis and screening strategies for detection of familial hypercholesterolaemia in children and adolescents in Italy: a survey from the LIPIGEN Paediatric Group","volume":"12","author":"Pederiva","year":"2025","journal-title":"Child Basel Switz"},{"key":"2026092914373098500_ehag382-B66","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/gim.2015.71","article-title":"Mutational analysis of a cohort with clinical diagnosis of familial hypercholesterolemia: considerations for genetic diagnosis improvement","volume":"18","author":"Medeiros","year":"2016","journal-title":"Genet Med"},{"key":"2026092914373098500_ehag382-B67","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1056\/NEJMoa1602777","article-title":"Child\u2013parent familial hypercholesterolemia screening in primary care","volume":"375","author":"Wald","year":"2016","journal-title":"N Engl J Med"},{"key":"2026092914373098500_ehag382-B68","doi-asserted-by":"publisher","first-page":"e1046","DOI":"10.1016\/j.jacl.2024.08.007","article-title":"Challenges and opportunities for identifying people with familial hypercholesterolemia in the UK: evidence from the National FH PASS database","volume":"18","author":"Cox","year":"2024","journal-title":"J Clin Lipidol"},{"key":"2026092914373098500_ehag382-B69","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S2213-8587(25)00286-4","article-title":"Recent advances in research and care of familial hypercholesterolaemia","volume":"13","author":"Santos","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026092914373098500_ehag382-B70","doi-asserted-by":"publisher","first-page":"Doc04","DOI":"10.3205\/HTA000136","article-title":"The time is now: achieving FH paediatric screening across Europe\u2014the Prague Declaration","volume":"16","author":"Bedlington","year":"2022","journal-title":"GMS Health Innov Technol"},{"key":"2026092914373098500_ehag382-B71","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11883-019-0797-3","article-title":"The impact of the international cooperation on familial hypercholesterolemia screening and treatment: results from the ScreenPro FH Project","volume":"21","author":"Ceska","year":"2019","journal-title":"Curr Atheroscler Rep"},{"key":"2026092914373098500_ehag382-B72","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ijns7010015","article-title":"Neonatal screening in Europe revisited: an ISNS perspective on the current state and developments since 2010","volume":"7","author":"Loeber","year":"2021","journal-title":"Int J Neonatal Screen"},{"key":"2026092914373098500_ehag382-B73","doi-asserted-by":"publisher","first-page":"113469","DOI":"10.1016\/j.jpeds.2023.113469","article-title":"Familial hypercholesterolemia biomarker distribution in dried blood spots","volume":"259","author":"Held","year":"2023","journal-title":"J Pediatr"},{"key":"2026092914373098500_ehag382-B74","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/ijns8010014","article-title":"Analytical validation of familial hypercholesterolemia biomarkers in dried blood spots","volume":"8","author":"Held","year":"2022","journal-title":"Int J Neonatal Screen"},{"key":"2026092914373098500_ehag382-B75","doi-asserted-by":"publisher","first-page":"101262","DOI":"10.1016\/j.ajpc.2025.101262","article-title":"State-of-the-art review: the value of leveraging evidence and data (LEAD) in pediatric screening for familial hypercholesterolemia","volume":"23","author":"Flyer","year":"2025","journal-title":"Am J Prev Cardiol"},{"key":"2026092914373098500_ehag382-B76","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/jamacardio.2025.4047","article-title":"Genetic diagnosis of familial hypercholesterolemia in residual newborn dried blood spots","volume":"10","author":"Peterson","year":"2025","journal-title":"JAMA Cardiol"},{"key":"2026092914373098500_ehag382-B77","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.jacl.2018.05.011","article-title":"Pediatric lipid reference values in the general population: the Dutch lifelines cohort study","volume":"12","author":"Balder","year":"2018","journal-title":"J Clin Lipidol"},{"key":"2026092914373098500_ehag382-B78","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12916-021-01959-w","article-title":"Novel associations between parental and newborn cord blood metabolic profiles in the Norwegian mother, father and child cohort study","volume":"19","author":"\u00d8yri","year":"2021","journal-title":"BMC Med"},{"key":"2026092914373098500_ehag382-B79","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.1093\/eurheartj\/ehad547","article-title":"Significance of lipids, lipoproteins, and apolipoproteins during the first 14\u201316 months of life","volume":"44","author":"Taageby Nielsen","year":"2023","journal-title":"Eur Heart J"},{"key":"2026092914373098500_ehag382-B80","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1093\/eurheartj\/ehaf815","article-title":"LDL-cholesterol in newborns and children with genetically verified familial hypercholesterolaemia: implications for cholesterol-based screening","volume":"46","author":"Bogsrud","year":"2025","journal-title":"Eur Heart J"},{"key":"2026092914373098500_ehag382-B81","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/cge.14453","article-title":"Genetic identification of familial hypercholesterolemia within whole genome sequences in 6820 newborns","volume":"105","author":"Zhou","year":"2024","journal-title":"Clin Genet"},{"key":"2026092914373098500_ehag382-B82","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1093\/eurjpc\/zwae028","article-title":"Beyond early LDL cholesterol lowering to prevent coronary atherosclerosis in familial hypercholesterolaemia","volume":"31","author":"Ibrahim","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2026092914373098500_ehag382-B83","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/jamacardio.2021.3508","article-title":"Association between cumulative low-density lipoprotein cholesterol exposure during young adulthood and middle age and risk of cardiovascular events","volume":"6","author":"Zhang","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2026092914373098500_ehag382-B84","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/s0008-6363(01)00551-x","article-title":"A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors","volume":"54","author":"Cheng","year":"2002","journal-title":"Cardiovasc Res"},{"key":"2026092914373098500_ehag382-B85","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1001\/jama.292.3.331","article-title":"Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial","volume":"292","author":"Wiegman","year":"2004","journal-title":"JAMA"},{"key":"2026092914373098500_ehag382-B86","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1161\/CIRCULATIONAHA.116.025158","article-title":"Effect of rosuvastatin on carotid intima-Media thickness in children with heterozygous familial hypercholesterolemia: the CHARON study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)","volume":"136","author":"Braamskamp","year":"2017","journal-title":"Circulation"},{"key":"2026092914373098500_ehag382-B87","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","article-title":"20-Year Follow-up of statins in children with familial hypercholesterolemia","volume":"381","author":"Luirink","year":"2019","journal-title":"N Engl J Med"},{"key":"2026092914373098500_ehag382-B88","doi-asserted-by":"publisher","first-page":"zwae369","DOI":"10.1093\/eurjpc\/zwae369","article-title":"Evolocumab treatment reduces carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia","author":"Wiegman","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2026092914373098500_ehag382-B89","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.jcmg.2024.05.005","article-title":"Decreased LDL-cholesterol exposure following ANGPTL3 inhibition reduces coronary plaque development in homozygous familial hypercholesterolemia","volume":"17","author":"Schonck","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026092914373098500_ehag382-B90","doi-asserted-by":"publisher","first-page":"n1430","DOI":"10.1136\/bmj.n1430","article-title":"Shared decision-making: summary of NICE guidance","volume":"373","author":"Carmona","year":"2021","journal-title":"BMJ"},{"key":"2026092914373098500_ehag382-B91","doi-asserted-by":"publisher","first-page":"e2023062850","DOI":"10.1542\/peds.2023-062850","article-title":"A communication and decision-making framework for pediatric precision medicine","volume":"153","author":"Greene","year":"2024","journal-title":"Pediatrics"},{"key":"2026092914373098500_ehag382-B92","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41569-023-00892-0","article-title":"International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia","volume":"20","author":"Watts","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"2026092914373098500_ehag382-B93","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2012.10.032","article-title":"Statin treatment of children with familial hypercholesterolemia\u2013trying to balance incomplete evidence of long-term safety and clinical accountability: are we approaching a consensus?","volume":"226","author":"Vuorio","year":"2013","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B94","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S2352-4642(24)00073-7","article-title":"Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries","volume":"8","author":"Reijman","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"key":"2026092914373098500_ehag382-B95","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0140-6736(21)02001-8","article-title":"Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study","volume":"399","author":"Tromp","year":"2022","journal-title":"Lancet"},{"key":"2026092914373098500_ehag382-B96","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1001\/archinte.165.8.883","article-title":"Risk scores predict atherosclerotic lesions in young people","volume":"165","author":"McMahan","year":"2005","journal-title":"Arch Intern Med"},{"key":"2026092914373098500_ehag382-B97","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2022.04.003","article-title":"Lipoprotein(a) beyond the kringle IV repeat polymorphism: the complexity of genetic variation in the LPA gene","volume":"349","author":"Coassin","year":"2022","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B98","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1056\/NEJMoa2415818","article-title":"Lepodisiran \u2014 a long-duration small interfering RNA targeting lipoprotein(a)","volume":"392","author":"Nissen","year":"2025","journal-title":"N Engl J Med"},{"key":"2026092914373098500_ehag382-B99","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1161\/CIRCULATIONAHA.122.060667","article-title":"Lipoprotein(a) in youth and prediction of Major cardiovascular outcomes in adulthood","volume":"147","author":"Raitakari","year":"2023","journal-title":"Circulation"},{"key":"2026092914373098500_ehag382-B100","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/mol.0000000000000519","article-title":"Predicting cardiovascular disease in familial hypercholesterolemia","volume":"29","author":"Paquette","year":"2018","journal-title":"Curr Opin Lipidol"},{"key":"2026092914373098500_ehag382-B101","doi-asserted-by":"publisher","first-page":"e603","DOI":"10.1161\/CIR.0000000000000618","article-title":"Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association","volume":"139","author":"de Ferranti","year":"2019","journal-title":"Circulation"},{"key":"2026092914373098500_ehag382-B102","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijcard.2022.09.007","article-title":"E-cigarettes and myocardial infarction: a systematic review and meta-analysis","volume":"371","author":"Sharma","year":"2023","journal-title":"Int J Cardiol"},{"key":"2026092914373098500_ehag382-B103","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1177\/10998004241287782","article-title":"Comparing E-cigarettes and traditional cigarettes in relation to myocardial infarction, arrhythmias, and sudden cardiac death: a systematic review and meta-analysis","volume":"27","author":"Yacoub","year":"2025","journal-title":"Biol Res Nurs"},{"key":"2026092914373098500_ehag382-B104","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.atherosclerosis.2020.11.012","article-title":"Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: a computed tomographic angiography study","volume":"317","author":"P\u00e9rez De Isla","year":"2021","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B105","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/j.jcmg.2018.09.019","article-title":"Coronary artery calcium and cardiovascular events in patients with familial hypercholesterolemia receiving standard lipid-lowering therapy","volume":"12","author":"Miname","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026092914373098500_ehag382-B106","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.echo.2007.11.011","article-title":"Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American society of echocardiography carotid intima-media thickness task force endorsed by the Society for Vascular Medicine","volume":"21","author":"Stein","year":"2008","journal-title":"J Am Soc Echocardiogr"},{"key":"2026092914373098500_ehag382-B107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.athplu.2023.12.002","article-title":"CTCA in children with severe heterozygous familial hypercholesterolaemia: screening for subclinical atherosclerosis","volume":"55","author":"Reijman","year":"2024","journal-title":"Atheroscler Plus"},{"key":"2026092914373098500_ehag382-B108","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1542\/peds.2009-2107C","article-title":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report","volume":"128","author":"EXPERT PANEL ON INTEGRATED GUIDELINES FOR CARDIOVASCULAR HEALTH AND RISK REDUCTION IN CHILDREN AND ADOLESCENTS","year":"2011","journal-title":"Pediatrics"},{"key":"2026092914373098500_ehag382-B109","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1080\/10408398.2017.1392288","article-title":"Food groups and risk of coronary heart disease, stroke and heart failure: a systematic review and dose-response meta-analysis of prospective studies","volume":"59","author":"Bechthold","year":"2019","journal-title":"Crit Rev Food Sci Nutr"},{"key":"2026092914373098500_ehag382-B110","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.numecd.2020.12.002","article-title":"Dietary intake and lipid levels in Norwegian and Spanish children with familial hypercholesterolemia","volume":"31","author":"Rodr\u00edguez-Borjabad","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2026092914373098500_ehag382-B111","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s13668-013-0064-0","article-title":"Dietary cholesterol and plasma lipoprotein profiles: randomized controlled trials","volume":"2","author":"Griffin","year":"2013","journal-title":"Curr Nutr Rep"},{"key":"2026092914373098500_ehag382-B112","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3945\/ajcn.114.100305","article-title":"Dietary cholesterol and cardiovascular disease: a systematic review and meta-analysis","volume":"102","author":"Berger","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"2026092914373098500_ehag382-B113","doi-asserted-by":"publisher","first-page":"117433","DOI":"10.1016\/j.atherosclerosis.2023.117433","article-title":"Dietary fat quality, plasma atherogenic lipoproteins, and atherosclerotic cardiovascular disease: an overview of the rationale for dietary recommendations for fat intake","volume":"389","author":"Christensen","year":"2024","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B114","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1161\/CIRCULATIONAHA.105.169251","article-title":"Dietary recommendations for children and adolescents: a guide for practitioners: consensus statement from the American Heart Association","volume":"112","author":"Gidding","year":"2005","journal-title":"Circulation"},{"key":"2026092914373098500_ehag382-B115","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"2026092914373098500_ehag382-B116","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jacl.2021.09.049","article-title":"Saturated fats and cardiovascular health: current evidence and controversies","volume":"15","author":"Maki","year":"2021","journal-title":"J Clin Lipidol"},{"key":"2026092914373098500_ehag382-B117","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.nut.2013.08.014","article-title":"Association of fructose consumption and components of metabolic syndrome in human studies: a systematic review and meta-analysis","volume":"30","author":"Kelishadi","year":"2014","journal-title":"Nutrition"},{"key":"2026092914373098500_ehag382-B118","author":"AVIS r\u00e9vis\u00e9 de l\u2019Anses relatif \u00e0 l\u2019actualisation des rep\u00e8res alimentaires du PNNS\u2014Enfants (4 \u00e0 17 ans)"},{"key":"2026092914373098500_ehag382-B119","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1017\/S1368980012000973","article-title":"Breakfast consumption and CVD risk factors in European adolescents: the HELENA (Healthy Lifestyle in Europe by Nutrition in Adolescence) study","volume":"16","author":"Hallstr\u00f6m","year":"2013","journal-title":"Public Health Nutr"},{"key":"2026092914373098500_ehag382-B120","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1017\/S1047951115000050","article-title":"Breakfast frequency, adiposity, and cardiovascular risk factors as markers in adolescents","volume":"26","author":"Cayres","year":"2016","journal-title":"Cardiol Young"},{"key":"2026092914373098500_ehag382-B121","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1542\/peds.107.2.256","article-title":"Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC)","volume":"107","author":"Obarzanek","year":"2001","journal-title":"Pediatrics"},{"key":"2026092914373098500_ehag382-B122","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1161\/CIRCULATIONAHA.108.191627","article-title":"Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association nutrition subcommittee of the council on nutrition, physical activity, and metabolism; council on cardiovascular nursing; and council on epidemiology and prevention","volume":"119","author":"Harris","year":"2009","journal-title":"Circulation"},{"key":"2026092914373098500_ehag382-B123","doi-asserted-by":"publisher","author":"Blomhoff","DOI":"10.6027\/nord2023-003"},{"key":"2026092914373098500_ehag382-B124","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1161\/01.CIR.99.6.779","article-title":"Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study","volume":"99","author":"De Lorgeril","year":"1999","journal-title":"Circulation"},{"key":"2026092914373098500_ehag382-B125","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2903\/j.efsa.2010.1462","article-title":"Scientific opinion on dietary reference values for carbohydrates and dietary fibre","volume":"8","author":"EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA)","year":"2010","journal-title":"EFSA J"},{"key":"2026092914373098500_ehag382-B126","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1161\/CIRCULATIONAHA.107.699447","article-title":"Impact of repeated dietary counseling between infancy and 14 years of age on dietary intakes and Serum lipids and lipoproteins","volume":"116","author":"Niinikoski","year":"2007","journal-title":"Circulation"},{"key":"2026092914373098500_ehag382-B127","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.3390\/nu12082436","article-title":"Diet and cardiovascular disease risk among individuals with familial hypercholesterolemia: systematic review and meta-analysis","volume":"12","author":"Barkas","year":"2020","journal-title":"Nutrients"},{"key":"2026092914373098500_ehag382-B128","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.3390\/nu10121842","article-title":"Decreasing the cholesterol burden in heterozygous familial hypercholesterolemia children by dietary plant stanol esters","volume":"10","author":"Vuorio","year":"2018","journal-title":"Nutrients"},{"key":"2026092914373098500_ehag382-B129","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jpeds.2005.11.023","article-title":"Plant stanols do not restore endothelial function in pre-pubertal children with familial hypercholesterolemia despite reduction of low-density lipoprotein cholesterol levels","volume":"148","author":"Jakulj","year":"2006","journal-title":"J Pediatr"},{"key":"2026092914373098500_ehag382-B130","doi-asserted-by":"publisher","first-page":"CD001918","DOI":"10.1002\/14651858.CD001918.pub3","article-title":"Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia","volume":"2014","author":"Malhotra","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2026092914373098500_ehag382-B131","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1017\/jns.2013.27","article-title":"Children and young adults with familial hypercholesterolaemia (FH) have healthier food choices particularly with respect to dietary fat sources compared with non-FH children","volume":"2","author":"Molven","year":"2013","journal-title":"J Nutr Sci"},{"key":"2026092914373098500_ehag382-B132","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2016.07.913","article-title":"Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia","volume":"252","author":"Torvik","year":"2016","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B133","doi-asserted-by":"publisher","first-page":"e472","DOI":"10.1161\/CIR.0000000000001031","article-title":"2021 dietary guidance to improve cardiovascular health: a scientific statement from the American Heart Association","volume":"144","author":"Lichtenstein","year":"2021","journal-title":"Circulation"},{"key":"2026092914373098500_ehag382-B134","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/ajcn\/77.5.1146","article-title":"Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials","volume":"77","author":"Mensink","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"2026092914373098500_ehag382-B135","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1080\/14656566.2020.1832991","article-title":"Advances with lipid-lowering drugs for pediatric patients with familial hypercholesterolemia","volume":"22","author":"Ferrari","year":"2021","journal-title":"Expert Opin Pharmacother"},{"key":"2026092914373098500_ehag382-B136","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jpeds.2015.05.006","article-title":"Efficacy and safety of pitavastatin in children and adolescents at high future cardiovascular risk","volume":"167","author":"Braamskamp","year":"2015","journal-title":"J Pediatr"},{"key":"2026092914373098500_ehag382-B137","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jacl.2015.07.011","article-title":"Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: results from the CHARON study","volume":"9","author":"Braamskamp","year":"2015","journal-title":"J Clin Lipidol"},{"key":"2026092914373098500_ehag382-B138","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.jacc.2017.06.058","article-title":"Efficacy of rosuvastatin in children with homozygous familial hypercholesterolemia and association with underlying genetic mutations","volume":"70","author":"Stein","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026092914373098500_ehag382-B139","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0022-3476(03)00186-0","article-title":"Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial","volume":"143","author":"McCrindle","year":"2003","journal-title":"J Pediatr"},{"key":"2026092914373098500_ehag382-B140","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0021-9150(99)00435-9","article-title":"Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia","volume":"150","author":"Raal","year":"2000","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B141","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1080\/08035250600702602","article-title":"Efficacy and safety of fluvastatin in children and adolescents with heterozygous familial hypercholesterolaemia","volume":"95","author":"Van Der Graaf","year":"2006","journal-title":"Acta Paediatr"},{"key":"2026092914373098500_ehag382-B142","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1001\/jama.281.2.137","article-title":"Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial","volume":"281","author":"Stein","year":"1999","journal-title":"JAMA"},{"key":"2026092914373098500_ehag382-B143","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1542\/peds.2004-2090","article-title":"Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia","volume":"116","author":"Clauss","year":"2005","journal-title":"Pediatrics"},{"key":"2026092914373098500_ehag382-B144","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1161\/01.CIR.0000035247.42888.82","article-title":"Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin","volume":"106","author":"De Jongh","year":"2002","journal-title":"Circulation"},{"key":"2026092914373098500_ehag382-B145","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.jpeds.2015.02.043","article-title":"Efficacy and safety of ezetimibe monotherapy in children with heterozygous familial or nonfamilial hypercholesterolemia","volume":"166","author":"Kusters","year":"2015","journal-title":"J Pediatr"},{"key":"2026092914373098500_ehag382-B146","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jacc.2008.09.002","article-title":"Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia","volume":"52","author":"Van Der Graaf","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026092914373098500_ehag382-B147","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1001\/jamapediatrics.2023.6477","article-title":"Alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: a randomized clinical trial","volume":"178","author":"Santos","year":"2024","journal-title":"JAMA Pediatr"},{"key":"2026092914373098500_ehag382-B148","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa2019910","article-title":"Evolocumab in pediatric heterozygous familial hypercholesterolemia","volume":"383","author":"Santos","year":"2020","journal-title":"N Engl J Med"},{"key":"2026092914373098500_ehag382-B149","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/S2213-8587(22)00221-2","article-title":"Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT","volume":"10","author":"Santos","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026092914373098500_ehag382-B150","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1161\/ATVBAHA.123.320268","article-title":"Evolocumab treatment in pediatric patients with homozygous familial hypercholesterolemia: pooled data from three open-label studies","volume":"44","author":"Raal","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026092914373098500_ehag382-B151","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S2213-8587(25)00351-1","article-title":"Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trial","volume":"14","author":"Wiegman","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026092914373098500_ehag382-B152","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1161\/CIRCULATIONAHA.124.073233","article-title":"Efficacy and safety of inclisiran in adolescents with genetically confirmed homozygous familial hypercholesterolemia: results from the double-blind, placebo-controlled part of the ORION-13 randomized trial","volume":"151","author":"Wiegman","year":"2025","journal-title":"Circulation"},{"key":"2026092914373098500_ehag382-B153","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jpeds.2009.08.037","article-title":"Colesevelam hydrochloride: efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemia","volume":"156","author":"Stein","year":"2010","journal-title":"J Pediatr"},{"key":"2026092914373098500_ehag382-B154","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1161\/CIRCULATIONAHA.123.065529","article-title":"Evinacumab for pediatric patients with homozygous familial hypercholesterolemia","volume":"149","author":"Wiegman","year":"2024","journal-title":"Circulation"},{"key":"2026092914373098500_ehag382-B155","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S2213-8587(24)00233-X","article-title":"Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study","volume":"12","author":"Masana","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026092914373098500_ehag382-B156","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.jacl.2016.05.010","article-title":"A 3-year study of atorvastatin in children and adolescents with heterozygous familial hypercholesterolemia","volume":"10","author":"Langslet","year":"2016","journal-title":"J Clin Lipidol"},{"key":"2026092914373098500_ehag382-B157","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jacl.2017.11.009","article-title":"Treatment goal attainment in children with familial hypercholesterolemia: a cohort study of 302 children in Norway","volume":"12","author":"Bogsrud","year":"2018","journal-title":"J Clin Lipidol"},{"key":"2026092914373098500_ehag382-B158","doi-asserted-by":"publisher","first-page":"CD006401","DOI":"10.1002\/14651858.CD006401.pub5","article-title":"Statins for children with familial hypercholesterolemia","volume":"2019","author":"Vuorio","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2026092914373098500_ehag382-B159","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.pedhc.2020.11.007","article-title":"The effect of statins in children and adolescents with familial hypercholesterolemia: a systematic review","volume":"35","author":"Dombalis","year":"2021","journal-title":"J Pediatr Health Care"},{"key":"2026092914373098500_ehag382-B160","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jpeds.2019.03.032","article-title":"Intermediate-term efficacy and tolerance of statins in children","volume":"210","author":"Mamann","year":"2019","journal-title":"J Pediatr"},{"key":"2026092914373098500_ehag382-B161","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cjco.2020.06.002","article-title":"Effectiveness and safety of statin therapy in children: a real-world clinical practice experience","volume":"2","author":"Kavey","year":"2020","journal-title":"CJC Open"},{"key":"2026092914373098500_ehag382-B162","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s40272-014-0116-y","article-title":"Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence","volume":"17","author":"Braamskamp","year":"2015","journal-title":"Pediatr Drugs"},{"key":"2026092914373098500_ehag382-B163","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.atherosclerosis.2015.05.034","article-title":"Gonadal steroids, gonadotropins and DHEAS in young adults with familial hypercholesterolemia who had initiated statin therapy in childhood","volume":"241","author":"Braamskamp","year":"2015","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B164","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1001\/jama.2014.8892","article-title":"Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia","volume":"312","author":"Kusters","year":"2014","journal-title":"JAMA"},{"key":"2026092914373098500_ehag382-B165","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.acap.2017.02.006","article-title":"Statin use and the risk of type 2 diabetes mellitus in children and adolescents","volume":"17","author":"Joyce","year":"2017","journal-title":"Acad Pediatr"},{"key":"2026092914373098500_ehag382-B166","doi-asserted-by":"publisher","first-page":"120659","DOI":"10.1016\/j.atherosclerosis.2026.120659","article-title":"Statin-associated symptoms and statin intolerance in children with familial hypercholesterolemia: insights from 15 years of clinical practice","volume":"414","author":"Van Den Bosch","year":"2026","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B167","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/MPG.0000000000002174","article-title":"Hepatotoxicity of statins as determined by serum alanine aminotransferase in a pediatric cohort with dyslipidemia","volume":"68","author":"Desai","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2026092914373098500_ehag382-B168","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jpeds.2017.02.047","article-title":"Statin-associated myopathy in a pediatric preventive cardiology practice","volume":"185","author":"Johnson","year":"2017","journal-title":"J Pediatr"},{"key":"2026092914373098500_ehag382-B169","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S2213-8587(24)00313-9","article-title":"Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trial","volume":"13","author":"Raal","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026092914373098500_ehag382-B170","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.athplu.2023.01.001","article-title":"Young women with familial hypercholesterolemia have higher LDL-cholesterol burden than men: novel data using repeated measurements during 12-years follow-up","volume":"51","author":"Johansen","year":"2023","journal-title":"Atheroscler Plus"},{"key":"2026092914373098500_ehag382-B171","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00431-025-06397-x","article-title":"Sex differences in lipid profile and response to statin treatment in pediatric patients affected by familial hypercholesterolemia","volume":"184","author":"Tarissi De Jacobis","year":"2025","journal-title":"Eur J Pediatr"},{"key":"2026092914373098500_ehag382-B172","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2021.09.003","article-title":"Loss of statin treatment years during pregnancy and breastfeeding periods in women with familial hypercholesterolemia","volume":"335","author":"Klevmoen","year":"2021","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B173","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/S0140-6736(22)01545-8","article-title":"Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials","volume":"400","author":"Reith","year":"2022","journal-title":"Lancet"},{"key":"2026092914373098500_ehag382-B174","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jacl.2014.02.011","article-title":"An assessment by the statin liver safety task force: 2014 update","volume":"8","author":"Bays","year":"2014","journal-title":"J Clin Lipidol"},{"key":"2026092914373098500_ehag382-B175","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S2213-8587(24)00040-8","article-title":"Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis","volume":"12","author":"Reith","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026092914373098500_ehag382-B176","doi-asserted-by":"publisher","first-page":"e2231097","DOI":"10.1001\/jamanetworkopen.2022.31097","article-title":"Analysis of insulin resistance among children and adolescents in Slovenia with hypercholesterolemia after treatment with statins","volume":"5","author":"Groselj","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026092914373098500_ehag382-B177","doi-asserted-by":"publisher","first-page":"118598","DOI":"10.1016\/j.atherosclerosis.2024.118598","article-title":"Efficacy and safety of statins, ezetimibe and statins-ezetimibe therapies for children and adolescents with heterozygous familial hypercholesterolaemia: systematic review, pairwise and network meta-analyses of randomised controlled trials","volume":"401","author":"Llewellyn","year":"2025","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B178","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/eurjpc\/zwad332","article-title":"Evolocumab in paediatric heterozygous familial hypercholesterolaemia: cognitive function during 80 weeks of open-label extension treatment","volume":"31","author":"Santos","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2026092914373098500_ehag382-B179","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2012.02.019","article-title":"Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment","volume":"223","author":"Raal","year":"2012","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B180","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1136\/hrt.76.1.84","article-title":"Aortic stenosis in homozygous familial hypercholesterolaemia","volume":"76","author":"Rallidis","year":"1996","journal-title":"Heart"},{"key":"2026092914373098500_ehag382-B181","doi-asserted-by":"publisher","first-page":"117525","DOI":"10.1016\/j.atherosclerosis.2024.117525","article-title":"Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: an expert consensus statement from ERKNet and ESPN","volume":"392","author":"Reijman","year":"2024","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B182","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jcmg.2025.07.022","article-title":"Photon-counting computed tomography in cardiac imaging","volume":"19","author":"Shiyovich","year":"2026","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026092914373098500_ehag382-B183","doi-asserted-by":"publisher","first-page":"ehaf1118","DOI":"10.1093\/eurheartj\/ehaf1118","article-title":"Photon-counting computed tomography: a revolution in cardiac imaging","author":"Pontone","year":"2026","journal-title":"Eur Heart J"},{"key":"2026092914373098500_ehag382-B184","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1194\/jlr.RA120000888","article-title":"Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance","volume":"61","author":"Adam","year":"2020","journal-title":"J Lipid Res"},{"key":"2026092914373098500_ehag382-B185","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1093\/eurheartj\/ehae325","article-title":"Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy","volume":"45","author":"Gaudet","year":"2024","journal-title":"Eur Heart J"},{"key":"2026092914373098500_ehag382-B186","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.atherosclerosis.2021.04.014","article-title":"Marked plaque regression in homozygous familial hypercholesterolemia","volume":"327","author":"Reeskamp","year":"2021","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B187","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1194\/jlr.R200014-JLR200","article-title":"Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly","volume":"44","author":"Hussain","year":"2003","journal-title":"J Lipid Res"},{"key":"2026092914373098500_ehag382-B188","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/CIRCULATIONAHA.113.001292","article-title":"Lomitapide and mipomersen","volume":"129","author":"Rader","year":"2014","journal-title":"Circulation"},{"key":"2026092914373098500_ehag382-B189","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jacl.2018.10.011","article-title":"Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: a systematic review","volume":"13","author":"Luirink","year":"2019","journal-title":"J Clin Lipidol"},{"key":"2026092914373098500_ehag382-B190","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.atherosclerosis.2020.01.031","article-title":"Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: data from an international registry","volume":"299","author":"Luirink","year":"2020","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B191","doi-asserted-by":"publisher","first-page":"e304","DOI":"10.1161\/ATV.0000000000000177","article-title":"Lipoprotein apheresis: utility, outcomes, and implementation in clinical practice: a scientific statement from the American Heart Association","volume":"44","author":"Gianos","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026092914373098500_ehag382-B192","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jacl.2019.05.002","article-title":"A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolemia: the Sino-Roman study","volume":"13","author":"Stefanutti","year":"2019","journal-title":"J Clin Lipidol"},{"key":"2026092914373098500_ehag382-B193","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.amjcard.2008.06.049","article-title":"Long-term safety and efficacy of low-density lipoprotein apheresis in childhood for homozygous familial hypercholesterolemia","volume":"102","author":"Hudgins","year":"2008","journal-title":"Am J Cardiol"},{"key":"2026092914373098500_ehag382-B194","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0021-9150(00)00371-3","article-title":"The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels","volume":"152","author":"Kroon","year":"2000","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B195","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.atherosclerosis.2009.06.010","article-title":"Efficacy criteria and cholesterol targets for LDL apheresis","volume":"208","author":"Thompson","year":"2010","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B196","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/MOL.0000000000001007","article-title":"Liver transplantation for homozygous familial hypercholesterolaemia","volume":"36","author":"Thompson","year":"2025","journal-title":"Curr Opin Lipidol"},{"key":"2026092914373098500_ehag382-B197","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1161\/01.CIR.0000116766.31036.03","article-title":"Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia","volume":"109","author":"Salen","year":"2004","journal-title":"Circulation"},{"key":"2026092914373098500_ehag382-B198","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1056\/NEJMoa1501365","article-title":"A phase 3 trial of sebelipase alfa in lysosomal acid lipase deficiency","volume":"373","author":"Burton","year":"2015","journal-title":"N Engl J Med"},{"key":"2026092914373098500_ehag382-B199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2019.09.005","article-title":"Current management of children and young people with heterozygous familial hypercholesterolaemia\u2014HEART UK statement of care","volume":"290","author":"Ramaswami","year":"2019","journal-title":"Atherosclerosis"},{"key":"2026092914373098500_ehag382-B200","doi-asserted-by":"publisher","first-page":"e038458","DOI":"10.1161\/JAHA.124.038458","article-title":"Life course approach for managing familial hypercholesterolemia","volume":"14","author":"Gidding","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"2026092914373098500_ehag382-B201","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11883-023-01090-6","article-title":"How can implementation science improve the care of familial hypercholesterolaemia?","volume":"25","author":"Sarkies","year":"2023","journal-title":"Curr Atheroscler Rep"},{"key":"2026092914373098500_ehag382-B202","doi-asserted-by":"publisher","first-page":"100452","DOI":"10.1016\/j.fhj.2025.100452","article-title":"Creating system-wide change in medicine: the role of implementation science in achieving scale and adoption","volume":"12","author":"Barry","year":"2025","journal-title":"Future Healthc J"},{"key":"2026092914373098500_ehag382-B203","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1001\/jamacardio.2019.5173","article-title":"Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action","volume":"5","author":"Representatives of the Global Familial Hypercholesterolemia Community","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2026092914373098500_ehag382-B204","doi-asserted-by":"publisher","first-page":"531","DOI":"10.5551\/jat.CR006","article-title":"Guidelines for the diagnosis and treatment of pediatric familial hypercholesterolemia 2022","volume":"30","author":"Harada-Shiba","year":"2023","journal-title":"J Atheroscler Thromb"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/26\/3324\/68372002\/ehag382.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/26\/3324\/68372002\/ehag382.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:37:43Z","timestamp":1790707063000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/26\/3324\/8691080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":204,"journal-issue":{"issue":"26","published-online":{"date-parts":[[2026,5,25]]},"published-print":{"date-parts":[[2026,7,7]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag382","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,7]]},"published":{"date-parts":[[2026,5,25]]}}}